1. Home
  2. AEIS vs CYTK Comparison

AEIS vs CYTK Comparison

Compare AEIS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advanced Energy Industries Inc.

AEIS

Advanced Energy Industries Inc.

HOLD

Current Price

$257.41

Market Cap

8.2B

Sector

Technology

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.77

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEIS
CYTK
Founded
1981
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.0B
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
AEIS
CYTK
Price
$257.41
$63.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
16
Target Price
$223.20
$82.38
AVG Volume (30 Days)
368.5K
2.2M
Earning Date
02-11-2026
02-26-2026
Dividend Yield
0.17%
N/A
EPS Growth
236.95
N/A
EPS
3.81
N/A
Revenue
$1,724,842,000.00
$87,211,000.00
Revenue This Year
$22.67
$339.72
Revenue Next Year
$12.82
$79.08
P/E Ratio
$62.37
N/A
Revenue Growth
17.19
2609.26
52 Week Low
$75.01
$29.31
52 Week High
$238.92
$70.98

Technical Indicators

Market Signals
Indicator
AEIS
CYTK
Relative Strength Index (RSI) 71.66 50.55
Support Level $201.56 $60.30
Resistance Level $232.00 $65.08
Average True Range (ATR) 9.00 2.78
MACD 2.87 0.10
Stochastic Oscillator 95.29 60.66

Price Performance

Historical Comparison
AEIS
CYTK

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: